MedStar Georgetown Transplant Institute offers expertise in organ transplant medicine, surgery, and procedures, treating patients with diseases of the liver, pancreas, kidneys, and small bowel. The Institute is one of the highest volume organ transplant programs in the country and offers the expertise of some of the foremost US transplant specialists. The institute has performed more than 10,000 liver, kidney, pancreas, small bowel, and multi-organ transplants. With nine surgeons and more than 20 physicians, the institute transplants more than 300 solid organs a year at MedStar Georgetown University Hospital.
The MGTI, created in 2010, merged all organ transplant programs in the MedStar Health network. MedStar Georgetown University Hospital, the base of operations for transplant surgery, is a large, not-for-profit, tertiary-care teaching hospital located in Northwest Washington, D.C. MGTI is the largest national program by volume for pancreas transplants and among the top 2 intestinal transplant programs by volume with patients from 15 countries.
Recent Leadership News
Gabriel Gondolesi, MD, director of Pediatric Liver Transplantation and associate director of Intestinal Transplantation at MedStar Georgetown Transplant Institute, has been named president-elect of The Transplantation Society, with his two-year term beginning in September 2026.
Facts compiled by Executive Moves from publicly available news and press releases on 17 July 2026. Spotted an inaccuracy? Email us and we'll review within 1 business day.
To upgrade to a Premium Profile reach out to us at info@executive-moves.com.
Are you on the MedStar Georgetown Transplant Institute team?
This is a Light company page, auto-generated from public news coverage. Claim it to verify the company description, add logo and links, and control how your organisation is represented on Executive Moves.
Claim this company →
